The Valley Desk

NCT00028002 · Interventional trial

Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor

Overall registry status Completed

Phase 2

Conditions Gastrointestinal Stromal Tumor

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov